Steve Oswald
Analyst · Canaccord. Your line is open
Okay. Thank you, Chris. Thanks everyone for joining us for our fourth quarter conference call. As in our second and third quarter calls, I first hope you and your families are healthy, continue to get through this pandemic as best as possible. Today, and as usual, I will give an update of the current situation of the company, after which Chris Wampler will review our financials in detail. The company remains focused first and foremost on the health and safety of our employees. The team has done an excellent job with the safety protocols put in place since March last year. We continue to work with the authorities on best practices throughout our many operations. Amount of cases now is 188 for the company since last March. We remain diligent on communications with weekly updates through our Human Resources team. As mentioned in the press release Ducommun's fourth quarter results really shined in despite the continued unprecedented challenges in the commercial aerospace markets. All our actions, initiatives, and hard work since we began this journey in 2017, have shown in the strong operating results, and again in Q4. Our defense business continues to be a major contributor along with cost reductions, having the right product portfolio, strong operating leadership and leveraging our lean and highly focused performance centers. This is particularly evident in the margin expansions for gross profit and adjusted EBITDA, despite the massive year-over-year headwind. Team also posted adjusted operating income margins of over 8% in line with expectations. Quality of our earnings too was very high, with the company reaching GAAP diluted EPS of $0.80 a share versus $0.75 a share for Q4, 2019, and adjusted diluted EPS of $0.89 a share, versus $0.80 in 2019. These numbers [are reads 0:05:06] despite overall revenue being down 15.6% from Q4 last year, a job well done. This is a great story for our investors, as we see a return to growth in 2021 with commercial aerospace recovering, and the solid results in 2020 will benefit the future numbers. The company's fourth quarter revenue was lower due to the commercial aerospace markets, and roughly at the midpoint of our expectations of being down between 14% and 18%, which was communicated in our last earnings call. Ducommun's defense business, however, again showed great strength, being up 25% versus prior year, and again a result of the many improvements that we started back in 2018. Our timing was excellent. So not everyone has shown negative growth. The revenue number is also impressive, for not only the pandemic impact, but also overcoming another $24 million of 737 MAX headwind in Q4. Ducommun's defense business continues to show excellent progress on shipments and business development. The majority of the gains in Q4 included radar systems for Northrop Grumman, increases from our new weapons systems business, Nobles Worldwide, along with the Patriot, UAVs at General Atomics, F-35, MIR and the Raytheon TOW program. I mentioned on our last call about Ducommun's new efforts with UAVs. Again, we are thrilled to be a strategic partner with GA, and they're now reaching a million dollars in revenue in December 2020 as we had hoped. The number was still strong. And shipments in 2021 for this customer will be over 4x versus last year. In regard to defense backlog, we set an all-time record for Ducommun ending Q4 with a backlog of $530 million. The total backlog was $822 million for the company, sequentially up from Q3, that's a great number based on the environment. The defense business grew year-over-year by 25%, bolstered by strong revenues across numerous key platforms which included, F-35, Patriot, the TOW Missile, Mir Missile, UAVs, weapon systems for ground vehicles at Nobles and others, as this part of Ducommun continues to deliver. Obviously, the strength help offset commercial aerospace orders, which we anticipate will start increasing in 2021. Defense results also show great opportunities where we can leverage our structural product lines with defense OEMs. We have major wins now in the TOW Missile, which I spoken about and other new programs, and along with acquisitions this part of the business will be north of $100 million revenue for 2021. I also want to mention that we are optimistic about defense going forward, despite concerns regarding the budget and change in administration. Ducommun defense segment was under managed in the past, but now its structural applications going full speed, along with the long-term track record and value offering of our electronic systems business, we see a strong future. As in Q3, costs actions have continued in Q4. You can certainly see the effectiveness of our actions in the positive gross profit margin expansion year-over-year, and solid operating income percentage along with EPS. Team did a great job in 2020, moving quickly, and managing this difficult environment with no material pandemic related costs incurred, including major restructuring or impairments. In regards to the outlook, our significant backlog in defense, the many growth programs mentioned earlier will provide strong revenue in 2021. We estimate that revenues will led by defense, but over the quarters and years ahead we will see more commercial aerospace volume return to Ducommun. We have the capacity, the strong operating team and are prepared for the rate increases, especially in single aisle aircraft. We also see Ducommun's titanium business of hot form and super plastic forming leading this comeback as well. We are a leader in this area with only OEM operations we know of at Airbus. Ducommun has a strong position in titanium already at Boeing, Spirit Aerosystem, Gulfstream and among others. And you know we have been reporting over the past few years our efforts to evolve with significant franchise with Airbus, which continues to go well. As much our last call, we will return to growth in 2021, with the first quarter still having a tough compare and being down year-over-year. The other three quarters will see good growth versus 2020, and we anticipate overall revenue for the year of Ducommun growing low to mid-single-digits. Ducommun also has a great long-term future. This will be accomplished by leveraging our new built out defense portfolio spoken about earlier, which now is currently 52 programs above a $1 million in yearly revenue, and that's up from 34 in 2017, that's over 50% increase. Also Ducommun's strong position in commercial aerospace, especially on narrow body with roughly a two to one ratio with wide bodies. Our titanium market leadership, along with share gain at Airbus will drive excellent growth as the market recovers. Our engineered products portfolio and recent acquisitions will provide opportunities as well. And finally, we will also remain active in the market for M&A, and believe this will only be an accelerator to higher results in the future. Now, let me provide some additional color on our markets, products and programs. Beginning with our military and space sector, we posted fourth quarter revenue of $115.4 million, once again representing strong growth versus 2019, up 25%. We drove revenue across a broad variety of defense platforms, including most of our product portfolio. As mentioned earlier, we saw increases in demand for our military fixed wing aircraft programs, with particularly strong revenue as mentioned from Northrop Grumman, Nobles Worldwide, Patriot, GA, F-35, Mir and the TOW Missile. The fourth quarter military and space revenue represented 73% of Ducommun's revenue in the period. We also continue to be very well positioned for future growth across our defense platforms over the next several quarters in all sectors. And again, ended the fourth quarter with an all-time high backlog record of $530 million, which is up 70% year-over-year, and it also represents 65% of our current backlog. Within our commercial aerospace operations, fourth quarter revenue declined year-over-year to $37.2 million, as expected, driven by build rate declines on the 737 MAX, as well as many other programs impacted by COVID-19 pandemic. Ducommun also has effectively adjusted cost and managed the downturn is well positioned, once rates stabilize and increase over the long-term. Ducommun will begin to recover in this market in 2021, and as mentioned earlier, has a very bright future. The backlog within our commercial aerospace sector stands at roughly $268 million at the end of Q4, for the majority of the decline due to the 737 MAX. With that, I'll have Chris review our financial results in detail. Chris?